Citadel Advisors - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 42 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 2.7%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q1 2022$217,000
-24.7%
50,873
-17.9%
0.00%
Q4 2021$288,000
+60.0%
61,977
+37.7%
0.00%
Q3 2021$180,000
-31.8%
45,018
-27.0%
0.00%
Q2 2021$264,000
+149.1%
61,667
+145.7%
0.00%
Q1 2021$106,000
+2.9%
25,100
-4.9%
0.00%
Q4 2020$103,000
-65.0%
26,401
-63.8%
0.00%
Q3 2020$294,000
-43.8%
73,007
-40.6%
0.00%
Q2 2020$523,000
-18.2%
122,995
-19.1%
0.00%
Q1 2020$639,000
+126.6%
152,082
+112.2%
0.00%
Q4 2019$282,000
-31.1%
71,686
+54.2%
0.00%
Q3 2019$409,000
-22.7%
46,493
-18.7%
0.00%
Q2 2019$529,000
+462.8%
57,200
+291.8%
0.00%
Q1 2019$94,000
-92.3%
14,600
-88.8%
0.00%
-100.0%
Q4 2018$1,228,000
+52.9%
130,273
+226.5%
0.00%
Q3 2018$803,000
-62.1%
39,900
-45.1%
0.00%
-100.0%
Q2 2018$2,118,000
-10.0%
72,635
-8.1%
0.00%0.0%
Q1 2018$2,353,000
-22.6%
79,006
-16.4%
0.00%0.0%
Q4 2017$3,041,000
+173.2%
94,500
+195.3%
0.00%0.0%
Q3 2017$1,113,000
-88.1%
32,000
-89.8%
0.00%
-87.5%
Q2 2017$9,354,000
+24.9%
314,190
+25.2%
0.01%
+14.3%
Q1 2017$7,492,000
+1667.0%
250,980
+937.1%
0.01%
Q4 2016$424,000
-44.0%
24,200
-23.9%
0.00%
-100.0%
Q3 2016$757,000
-23.1%
31,800
-12.8%
0.00%0.0%
Q4 2015$984,000
-48.6%
36,452
-47.1%
0.00%
-50.0%
Q3 2015$1,915,00068,9100.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,914,970$81,007,00029.87%
RTW INVESTMENTS, LP 1,080,331$30,022,0009.33%
Avoro Capital Advisors LLC 804,299$22,351,0005.81%
ACUTA CAPITAL PARTNERS, LLC 122,222$3,397,0001.97%
Broadfin Capital, LLC 1,095,373$30,440,0001.69%
Belmont Global Advisors, Inc. 35,000$973,0001.65%
P.A.W. CAPITAL CORP 48,000$1,334,0001.53%
Perceptive Advisors 1,309,030$36,378,0001.45%
Iguana Healthcare Management, LLC 125,000$3,474,0001.37%
EAM Investors, LLC 97,350$2,705,0000.43%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders